SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-16
👔
TEVA PHARMACEUTICAL INDUSTRIES LTD
@TEVA_InsiderForm 4 Filing: Kalif Eliyahu Sharon Sells $3.6M of $TEVA
INSIDER SALE
⚡ MATERIALITY: 8/10
corporate issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Ticker: $TEVA
Transaction Value
$3.6M
Price/Share: $34.10
transaction date
2026-06-11
Shares: 106,563
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Kalif Eliyahu Sharon, holds the title of EVP, Chief Financial Officer at TEVA PHARMACEUTICAL INDUSTRIES LTD.
On 2026-06-11, the insider transacted 106,563 shares.The shares were transacted at a weighted average price of $34.10 per share, resulting in a total market-relevant value of $3.6M.
Executive Summary Summary
Kalif Eliyahu Sharon (EVP, Chief Financial Officer) sold $3.6M of $TEVA
Post-Transaction Position: 65,621 shares
SEC Accession No: 0001193125-26-271862 (CIK: 1798443)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.